The Food and Drug Administration on Wednesday disputed a drug company’s claim that pharmacies can no longer produce less expensive versions of a drug long used to reduce the risk that women will give birth prematurely.
The statement was aimed at defusing a controversy that erupted after the agency approved the drug Makena to prevent preterm births. Makena’s owner, KV Pharmaceutical of St. Louis, is charging $1,500 a dose for the drug. The same compound had been available for years for about $10 to $20 a dose.




Two priests, a nun and two women in their 60s who cut through fences at Naval Base Kitsap-Bangor to protest submarine nuclear weapons were sentenced Monday to prison terms ranging from two to 15 months.
Bad education policy is no excuse for cheating—especially cheating from principals and teachers, whom we hope will serve as role models for our kids.





























